Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome

International Journal of Laboratory Hematology

Volumn 31, Issue 6, 2009, Pages 630-638

  Hamdi, W ^a   Ogawara, H ^a   Handa, H ^a   Tsukamoto, N ^b   Murakami, H ^a  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

CD4 CD8 ratio; IFN c; IL 4; Intracellular cytokine; Myelodysplastic syndrome; Th1 Th2 ratio

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPENIA; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA; REFRACTORY ANEMIA WITH EXCESS BLAST 1; REFRACTORY ANEMIA WITH EXCESS BLAST 2; REFRACTORY ANEMIA WITH EXCESS BLASTS; REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; TH1 CELL; TH2 CELL; BIOSYNTHESIS; CD4 CD8 RATIO; IMMUNOLOGY; MIDDLE AGED; SIDEROBLASTIC ANEMIA;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA, REFRACTORY; ANEMIA, SIDEROBLASTIC; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-4; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TH1 CELLS; TH2 CELLS;

EID: 74049087403     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2008.01090.x     Document Type: Article

References (29)

1. Akahoshi M., Nakashima H., Tanaka Y., Kohsaka T., Nagano S., Ohgami E., Ar- inobu Y., Yamaoka K., Niiro H., Shino- zaki M., Hirakata H., Horiuchi T., Osuka T. &Niho Y. (1999) Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis and Rheumatism 42, 1644-1648.
2. Baumann M.A., Milson T.J., Patrick C.W., Libnoch J.A. &Keller R.H. (1986) Immunoregulatory abnormalities in myelodysplastic disorders. American Journal of Hematology 22, 17-26.
3. Barrett J., Saunthararajah Y. &Molldrem J. (2000) Myelodysplastic syndromes and aplastic anemia: distinct entities or diseases linked by a common patho- physiology. Seminars in Hematology 37, 15-29.
4. Bynoe A.G., Scott C.S., Ford P. &Roberts B.E. (1983) Decreased T-helper cells in the myelodysplastic syndromes. British Journal of Haematology 54, 97-102.
5. Carpani G., Rosti A. &Vosso N. (1989) T- lymphocyte subpopulations in myelo- dysplastic syndromes. Acta Haematology 81, 173-175.
6. Cheson B.D., Bennett J.M., Kantarjian H., Pinto A., Schiffer C.A., Nimer S.D., Lowenberg B., Beran M., de Witte T.M., Stone R.M., Mittelman M., Sanz G.F., Wijermans P.W., Gore S., Greenberg P.L. &World Health Organization (WHO) International Working Group. (2000) Report of an international working group to standardize response crite ria for myelodysplastic syndromes. Blood 96, 3671-3674.
7. Colombat P.H., Renoux M., Lamagnere J.P. &Renoux G. (1988) Immunologic indices in myelodysplastic syndromes. Cancer 61, 1075-1081.
8. Del Prete G.F., De Carli M., Mastromauro C., Biagiotti R., Macchia D., Falagiani P., Ricci M. &Romagnani S. (1991) Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. Journal of Clinical Investigation 88,346-350.
9. De Totero D., Reato G., Mauro F., Cignetti A., Ferrini S., Guarni A., Gobbi M., Grossi C.E. &Foa R. (1999) IL-4 production and increased CD30 expression by a unique CD8 T-cell subset in B- cell chronic lymphocytic leukaemia. British Journal of Haematologica 104,589-599.
10. Hamblin T.J. (1996) Immunological abnormalities in myelodysplastic syndromes. Seminars in Hematology 33,150-162.
11. Hill S.J., Peters S.H., Ayliffe J., Merceica J. &Bansal A.S. (1999) Reduced IL-4 and interferon-gamma (IFN-g) expression by CD4+ T cells in patients with chronic lymphocytic leukemia. Clinical and Experimental Immunology 117, 811.
12. Kay A.B., Ying S., Varney V., Gaga M., Durham S.R., Moqbel R., Wardlaw A.J. &Hamid Q. (1991) Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late- phase cutaneous reactions in atopic subjects. Journal of Experimental Medicine 173, 775-778.
13. Knox S.J., Greenberg B.R., Anderson R.W. &Rosenblatt L.S. (1983) Studies of T-lymphocytes in preleukemic disorders and acute nonlymphocytic leukemia: in vitro radiosensitivity, mitogenic responsiveness, colony formation, and enumeration of lymphocytic subpopula- tions. Blood 61, 449-455.
14. Liblau R.S., Singer S.M. &McDevitt H.O. (1995) Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunology Today 16,34-38.
15. Miescher P.A., Favre H. &Beris P. (1991) Autoimmune myelodysplasias. Seminars in Hematology 28, 322-330.
16. Mori T., Takada R., Watanabe R., Okam- oto S. &Ikebe Y. (2001) T-helper (Th)1/Th2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma. Cancer Immunology, Immunotherapy 50, 566-568.
17. Mosmann T.R. &Sad S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today 17, 138-146.
18. Ogawara H., Handa H., Morita K., Hayak- awa M., Kojima J., Amagai H., Tsumita Y., Kaneko Y., Tsukamoto N., Nojima Y. &Murakami H. (2003) High Th1/Th ratio in patients with chronic idiopathic thrombocytopenic purpura. European Journal of Hematology 71, 283-288.
19. Picker L.J., Singh M.K., Zdraveski Z., Treer J.R., Waldrop S.L., Bergstresser P.R. &Maino V.C. (1995) Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86, 1408-1419.
20. Romagnani S. (1994) Lymphokine production by human T cell in disease states. Annual Review of Immunology 12, 227-257.
21. Simon A.K., Seipelt E. &Sieper J. (1994) Divergent T-cell cytokine patterns in inflammatory arthritis. Proceedings of the National Academy of Sciences of the United States of America 91, 8562 8566.
22. mith M.A. &Smith J.G. (1991) The occurrence subtype and significance of hemopoietic inhibitory T cells (HIT cells) in myelodysplasia: an in vitro study. Leukemia Research 15, 597-601.
23. Sugawara T., Endo K., Shishido T., Sato A., Kameoka J., Fukuhara O., Yoshina- ga K. &Miura A. (1992) T-cell mediated inhibition of erythropoiesis in myeodysplastic syndrome. American Journal of Hematology 41, 304-305.
24. Symeonidis A., Kourakli A., Katevas P., Perraki M., Tiniakou M., Matsouka P., Georgoulias V. &Zoumbos N. (1991) Immune function parameters at diagnosis in patients with myelodysplastic syndromes: correlation with the FAB classification and prognosis. European Journal of Haematology 47(4), 277 281.
25. Tsicopoulos A., Hamid Q., Varney V., Ying S., Moqbel R., Durham S.R. &Kay A.B. (1992) Preferential messenger RNA expression of Th1-type cells (IFN- gamma ; IL-2 ;) in classical delayed- type (tuberculin) hypersensitivity reactions in human skin. Journal of Immunology 148, 2058-2061.
26. Tsuda H. &Yamasaki H. (2000) Type I and type II T-cell profiles in aplastic anemia and refractory anemia. American Journal of Hematology 64, 271274.
27. Voskuhl R.R., Martin R., Bergman C., Dalal M., Ruddle M.H. &McFarland H.F. (1993) T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15, 137-143.
28. Yatnda P., Mintz P., Grigoriadou K., Lem- onnier F., Vilmer E. &Langlade-Demo- yen P. (1999) Analysis of T-cell defects in the specific immune response against acute lymphoblastic leukemia cells. Experimental Hematology 27, 1375 1383.
29. Zhang X.-L., Komada Y., Chipeta J., Li Q.- S., Inaba H., Azuma E., Yamamoto H. &Sakurai M. (2000) Intracellular cytokine profile of T cells from children with acute lymphoblastic leukemia. Cancer Immunology, Immunotherapy 49, 165 172.